“EGFR inhibition potentiates FGFR inhibitor therapy and overcomes resistance in FGFR2 fusion-positive cholangiocarcinomaCombination Treatment in FGFR2-Fusion Cholangiocarcinoma.” Cancer Discovery.] The gene discussed is EGFR; the disease is cholangiocarcinoma.